Eli Lilly hikes Mounjaro price in UK for 2025
Pharmaceutical giant Eli Lilly announces a significant price increase for its diabetes and weight-loss drug Mounjaro in the UK, sparking concerns over affordability and access.
Pharmaceutical giant Eli Lilly announces a significant price increase for its diabetes and weight-loss drug Mounjaro in the UK, sparking concerns over affordability and access.
Former Florida Attorney General Pam Bondi faces ethics complaints for allegedly lobbying the Justice Department on behalf of a pharmaceutical company while serving on a federal drug enforcement board.
Apple is reportedly working on a major AI upgrade for Siri, transforming the voice assistant into a smarter, more intuitive tool across its devices.
A young Scottish student has been crowned Girl of the Year for her groundbreaking solar-powered blanket design, offering a sustainable solution to energy poverty.
A pharmaceutical executive faces charges after a horrific wrong-way collision claimed the life of a former Olympic swimmer. The shocking incident has sent shockwaves through the community.
A groundbreaking AI tool is set to transform bowel cancer detection in the NHS, potentially saving thousands of lives by identifying high-risk patients earlier.
A groundbreaking new therapy is transforming the lives of chronic pain sufferers, providing long-term relief that lasts for years. Discover how this innovative treatment could change pain management forever.
A unique hybrid boat named 'EV Shaun the Whale' is turning heads in Brisbane, blending eco-friendly technology with marine innovation. Discover how this vessel is setting a new standard for sustainable transport.
Groundbreaking CSI-inspired techniques are set to revolutionise cancer diagnosis and treatment in the UK, thanks to a major government-backed initiative.
A cutting-edge mRNA vaccine, similar to COVID-19 jabs, is being developed to combat pancreatic cancer—one of the deadliest forms of the disease. Promising early results offer hope for patients.
The pharmaceutical giant behind Mounjaro unveils an ambitious initiative to combat obesity in the UK, offering hope for millions struggling with weight-related health issues.
British patients will soon access cutting-edge American medical treatments as the NHS forms a landmark agreement with US regulators to fast-track innovative therapies.
In a surprising turn of events, Nvidia and AMD are leveraging outdated dial-up technology to rival OpenAI's GPT-5, sparking debates on the future of AI efficiency and accessibility.
A new butter alternative backed by Bill Gates, infused with carbon dioxide, has sparked outrage as critics call it 'disgusting'. The billionaire himself admits the product is 'strange'.
Australia is exploring cutting-edge undersea data centres powered by AI, aiming to boost efficiency and reduce environmental impact. Discover how this innovative project could reshape global tech infrastructure.
British farmers are leasing cemetery plots to grow crops in a bizarre yet profitable new trend. Discover how this unconventional method is helping them stay afloat amid rising costs.
The Trump administration has launched a review into Harvard University's patent policies, raising concerns over academic freedom and innovation.
Discover how a Pacific Islander transformed swimming by introducing the Australian crawl, now known as the freestyle stroke, to the world.
Walmart unveils innovative mobile stores to bring convenience directly to customers' neighbourhoods, reshaping the future of retail.
Pharmaceutical giant Eli Lilly is developing an oral weight loss drug that may compete with injectable treatments like Wegovy. Early trials show promising results, potentially offering a more convenient alternative for patients.
Apple CEO Tim Cook met with UK Chancellor Jeremy Hunt to discuss the country's thriving tech sector and potential investment opportunities.
Delhi authorities have busted a massive counterfeit drug operation, with fake versions of Johnson & Johnson and GSK products seized. The racket poses serious health risks to consumers.
The US Food and Drug Administration (FDA) has approved a new Alzheimer's treatment, sparking debate over its efficacy and high cost while offering hope to millions.
Australia’s leading scientific research agency, CSIRO, is set to cut hundreds of jobs amid significant budget reductions, sparking concerns over the nation’s innovation and climate research capabilities.
Shares in major European pharmaceutical firms plummet as investors react to potential US tariffs, sparking market volatility and sector-wide uncertainty.
OpenAI is reportedly developing a new AI model that can operate offline on smartphones, potentially transforming accessibility and privacy in AI technology.
Sales of Novo Nordisk's blockbuster diabetes medications, including Ozempic, have dropped unexpectedly. Experts weigh in on the causes and future implications.
Financial research firm Defaqto introduces innovative technology to transform banking services, offering smarter solutions for UK consumers and institutions.
The Productivity Commission proposes a new copyright exception for text and data mining, sparking debate between tech progress and creator rights.
In a groundbreaking move, an AI-powered candidate named 'AI Steve' is standing for election in Brighton Pavilion, challenging traditional politics with 24/7 accessibility and data-driven policies.